Profound Long Term Debt Total vs Short Term Investments Analysis
PROF Stock | USD 7.55 0.03 0.40% |
Profound Medical financial indicator trend analysis is much more than just breaking down Profound Medical Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Profound Medical Corp is a good investment. Please check the relationship between Profound Medical Long Term Debt Total and its Short Term Investments accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Long Term Debt Total vs Short Term Investments
Long Term Debt Total vs Short Term Investments Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Profound Medical Corp Long Term Debt Total account and Short Term Investments. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Profound Medical's Long Term Debt Total and Short Term Investments is -0.35. Overlapping area represents the amount of variation of Long Term Debt Total that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of Profound Medical Corp, assuming nothing else is changed. The correlation between historical values of Profound Medical's Long Term Debt Total and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt Total of Profound Medical Corp are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Long Term Debt Total i.e., Profound Medical's Long Term Debt Total and Short Term Investments go up and down completely randomly.
Correlation Coefficient | -0.35 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Long Term Debt Total
Short Term Investments
Short Term Investments is an item under the current assets section of Profound Medical balance sheet. It contains any investments Profound Medical Corp undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Profound Medical Corp can easily liquidate in the marketplace.Most indicators from Profound Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Profound Medical Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. At this time, Profound Medical's Sales General And Administrative To Revenue is most likely to increase slightly in the upcoming years. The Profound Medical's current Enterprise Value is estimated to increase to about 206.9 M, while Selling General Administrative is projected to decrease to roughly 6.9 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 303K | 174K | 932.8K | 731.0K | Depreciation And Amortization | 1.9M | 1.6M | 1.1M | 1.1M |
Profound Medical fundamental ratios Correlations
Click cells to compare fundamentals
Profound Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Profound Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 29.9M | 104.6M | 86.8M | 64.4M | 43.7M | 46.2M | |
Short Long Term Debt Total | 13.0M | 1.7M | 1.4M | 8.2M | 7.9M | 6.9M | |
Other Current Liab | 530.0K | 744K | 248K | 621K | 714.2K | 537.7K | |
Total Current Liabilities | 8.2M | 4.8M | 4.2M | 4.2M | 6.4M | 5.1M | |
Total Stockholder Equity | 14.3M | 97.4M | 80.6M | 52.0M | 31.2M | 36.2M | |
Property Plant And Equipment Net | 2.2M | 2.3M | 1.9M | 1.7M | 1.5M | 1.4M | |
Current Deferred Revenue | 501.2K | 358K | 477K | 471K | 721K | 384.1K | |
Net Debt | (3.8M) | (82.2M) | (65.8M) | (38.3M) | (18.2M) | (19.1M) | |
Retained Earnings | (100.3M) | (130.0M) | (160.7M) | (189.4M) | (217.9M) | (207.0M) | |
Accounts Payable | 3.0M | 3.4M | 3.2M | 2.0M | 3.3M | 2.6M | |
Cash | 14.7M | 83.9M | 67.2M | 46.5M | 26.2M | 32.4M | |
Non Current Assets Total | 7.2M | 6.9M | 9.7M | 2.4M | 2.0M | 1.9M | |
Cash And Short Term Investments | 14.7M | 83.9M | 67.2M | 46.5M | 26.1M | 33.2M | |
Net Receivables | 3.3M | 8.2M | 1.4M | 6.3M | 7.3M | 3.8M | |
Common Stock Total Equity | 98.4M | 120.9M | 130.3M | 211.5M | 243.3M | 255.4M | |
Common Stock Shares Outstanding | 11.1M | 17.3M | 20.5M | 20.8M | 21.2M | 12.5M | |
Liabilities And Stockholders Equity | 29.9M | 104.6M | 86.8M | 64.4M | 43.7M | 46.2M | |
Non Current Liabilities Total | 7.4M | 2.4M | 2.0M | 8.2M | 6.4M | 5.2M | |
Other Current Assets | 1.0M | 296.0K | 1.1M | 1.2M | 1.6M | 1.7M | |
Other Stockholder Equity | 15.0M | 73.2M | 80.8M | 85.7M | 19.7M | 32.6M | |
Total Liab | 15.6M | 7.3M | 6.2M | 12.4M | 12.7M | 10.1M | |
Total Current Assets | 22.7M | 97.7M | 77.1M | 62.0M | 41.9M | 41.4M | |
Accumulated Other Comprehensive Income | (89.7K) | 4.6M | 4.7M | 16.8M | 12.0M | 12.6M | |
Short Term Debt | 4.1M | 312K | 250K | 762K | 2.4M | 1.7M | |
Intangible Assets | 2.4M | 1.9M | 1.4M | 680K | 487.5K | 463.1K | |
Common Stock | 99.7M | 211.5M | 219.6M | 205.8M | 217.4M | 135.6M | |
Other Liab | 654K | 1.1M | 875K | 764K | 878.6K | 1.1M | |
Net Tangible Assets | 9.3M | 92.8M | 76.5M | 51.3M | 59.0M | 38.0M | |
Long Term Debt | 443.9K | 10.6M | 6.7M | 6.7M | 5M | 6.1M | |
Inventory | 3.6M | 5.3M | 7.4M | 7.9M | 7.0M | 4.3M | |
Short Long Term Debt | 4.7M | 1.3M | 5.1M | 523K | 2.1M | 2.6M |
Currently Active Assets on Macroaxis
When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.34) | Revenue Per Share 0.38 | Quarterly Revenue Growth 0.639 | Return On Assets (0.45) | Return On Equity (0.90) |
The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.